| Literature DB >> 19664921 |
Tao Wang1, John F Kadow, Zhongxing Zhang, Zhiwei Yin, Qi Gao, Dedong Wu, Dawn DiGiugno Parker, Zheng Yang, Lisa Zadjura, Brett A Robinson, Yi-Fei Gong, Timothy P Spicer, Wade S Blair, Pei-Yong Shi, Gregory Yamanaka, Pin-Fang Lin, Nicholas A Meanwell.
Abstract
4-Fluoro- and 4-methoxy-1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione (2 and 3, respectively) have been characterized as potent inhibitors of HIV-1 attachment that interfere with the interaction of viral gp120 with the host cell receptor CD4. As part of an effort to understand fundamental aspects of this pharmacophore, discovered originally using a high throughput cell-based screen, modification and substitution of the piperazine ring was examined in the context of compounds 6a-ah. The piperazine ring was shown to be a critical element of the HIV-1 attachment inhibiting pharmacophore, acting as a scaffold to deploy the indole glyoxamide and benzamide in a topographical relationship that complements the binding site on gp120.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19664921 DOI: 10.1016/j.bmcl.2009.07.076
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823